FDA record shows two 2024 Breyanzi approvals in lymphoma, one accelerated, one fullNov 9Regulatory decisionUpdated
Lyell reports Q3 2026 results, new ronde-cel data headed to ASHNov 4Quarterly updateLyell Immunopharma, Inc.
BMS: Reblozyl label supplement approved; GLORY CAR-T trial and BMS-986485 Phase 1 postedOct 22Weekly roundup, 4 itemsBristol Myers Squibbliso-celUpdated
BMS registers Phase 2 depression trial for BMS-986511; adds Alzheimer's PK study for BMS-986446Aug 21Weekly roundup, 6 itemsBristol Myers Squibbentecavir
Lyell reports Q2 2026 results, updated ronde-cel and LYL273 dataAug 6Quarterly updateLyell Immunopharma, Inc.
BMS trials post results across lung cancer, sarcoma, myelofibrosis; new stroke study opensJul 17Weekly roundup, 5 itemsBristol Myers Squibblisocabtagene maraleucel